Grosset, D. (2006) Experience of patients with Parkinson's disease in clinical practice. Round Table Series - Royal Society of Medicine(83), pp. 25-29.
Full text not currently available from Enlighten.
Abstract
Patients should be offered to switch from ergot-derived dopamine agonists to non-ergot-derived dopamine agonists. Where patients remain on these drugs, they should be screened and monitored for fibrotic complications, bearing in mind that the absence of symptoms may be false reassurance. The drugs should be withdrawn if pulmonary fibrosis or cardiac valve disease occurs.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Grosset, Professor Donald |
| Authors: | Grosset, D. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Psychology & Neuroscience |
| Journal Name: | Round Table Series - Royal Society of Medicine |
| Publisher: | Royal Society of Medicine |
| ISSN: | 0268-3091 |
| Related URLs: |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details